Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CanISleepinMS: Effect of cannabidiol on sleep quality in MS
2024-518280-35-00Phase 2Completed
- Sponsor
- Wageningen Research
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in Insomnia and multiple sclerosis (MS), sponsored by Wageningen Research. Primary endpoint: Insomnia Severity Index (ISI) questionnaire. Started Jan 2025; status: completed.
02
Drugs
cannabidiol
03
Conditions
Insomniamultiple sclerosis (MS)
Beyond the preview
Go deeper on 2024-518280-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518280-35-00.